Table 1.

The most cited articles on Fabry disease

Country	Authors	Year	Citations	Title
USA, France, UK, the Netherlands	Eng et al. (2001)	2001	976	Safety and efficacy of recombinant human alpha‐galactosidase a replacement therapy in Fabry's disease
USA	Schiffmann et al. (2001)	2001	841	Enzyme replacement therapy in Fabry disease – a randomized controlled trial
USA	Brady et al. (1967)	1967	832	Enzymatic defect in Fabry's disease – ceramidetrihexosidase deficiency
USA, Italy, Japan	Spada et al. (2006)	2006	490	High incidence of later‐onset Fabry disease revealed by newborn screening
Japan	Nakao et al. (1995)	1995	484	An atypical variant of Fabry's disease in men with left ventricular hypertrophy
UK, Italy, Switzerland, Belgium, Spain, Germany, Czech Republic, Austria	Mehta et al. (2004)	2004	432	Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
UK	MacDermot et al. (2001)	2001	425	Anderson–Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
USA, France	Desnick et al. (2003)	2003	389	Fabry disease, an under‐recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy
USA, Czech Republic, UK, Canada	Banikazemi et al. (2007)	2007	369	Agalsidase‐beta therapy for advanced Fabry disease – a randomized trial
UK, Japan	Sachdev et al. (2002)	2002	338	Prevalence of Anderson–Fabry disease in male patients with late onset hypertrophic cardiomyopathy